This is a limited company view. Sign up for a Free Trial to see everything.

Zyngenia is a biotherapeutics company focused on the development of the next-generation of antibody-derived drugs.

B2B
B2C
Biotechnology
Healthcare
Pharmaceuticals

Overview

Location

Gaithersburg

Founded

2009

Employees

13

Stage

Exited

Total funding

$25M

Last funding

7 years ago

Acquisitions

0

Growth score

9

Mindshare score

18

Scoring

Deals

$25.0M Series A

New Enterprise Associates

Sep 9, 2010

Employee Growth

Use Zyngenia's historical employee count to better understand their growth and spending over time.

Unlock with a Free Trial

Mobile

Use Zyngenia's mobile downloads and app ranks to evaluate the performance of their mobile apps.

Unlock with a Free Trial

Key People

Costumer support
HR Coordinator
scientist
Associate Scientist
Vice-President, Biopharmaceutical Research

Gain context with Mattermark Salesforce Enrichment

Find out how

Notes